The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cencora's share price is $237.95.
Cencora's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1,335.11. Hence, Cencora's PS Ratio for today is 0.18.
Warning Sign:
Cencora Inc stock PS Ratio (=0.18) is close to 5-year high of 0.18
The historical rank and industry rank for Cencora's PS Ratio or its related term are showing as below:
COR'
s PS Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.13 Max: 0.21
Current: 0.18
During the past 13 years, Cencora's highest PS Ratio was 0.21. The lowest was 0.09. And the median was 0.13.
COR's PS Ratio is ranked better than 81.25% of 96
companies
in the Medical Distribution industry
Industry Median: 0.495
vs COR: 0.18
Cencora's Revenue per Sharefor the
three
months ended in Dec. 2023 was $357.98.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1,335.11.
During the past 12 months, the average Revenue per Share Growth Rate of Cencora was 15.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 10.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 11.30% per year.
During the past 13 years, Cencora's highest 3-Year average Revenue per Share Growth Rate was 28.50% per year. The lowest was -27.30% per year. And the median was 11.30% per year.
Back to Basics: PS Ratio
Cencora PS Ratio Historical Data
The historical data trend for Cencora's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cencora's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora's PS Ratio Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cencora's PS Ratio falls into.
Cencora PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cencora's Share Price of today is $237.95.
Cencora's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,335.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cencora PS Ratio Related Terms
Thank you for viewing the detailed overview of Cencora's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COR has been successfully added to your 